These findings can be supported by the fact that in PRAD cases, upregulation of TMPRSS2 facilitates more activation of ACE2 receptors which further makes a host more susceptible to SARS-CoV-2 infection. Here, TMPRSS2 is linked to prostate adenocarcinoma.